Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicenter Study to Compare the Efficacy of Pegylated Interferon Alfa (PEG-IFN) in Combination With Two Different Doses of Ribavirin in Patients With Chronic Hepatitis C and Subtype 2/3

NCT01258101 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01258101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01258101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicenter Study to Compare the Efficacy of Pegylated Interferon Alfa (PEG-IFN) in Combination With Two Different Doses of Ribavirin in Patients With Chronic Hepatitis C and Subtype 2/3
Lead sponsor
Hoffmann-La Roche
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2003
Completion date
July 31, 2008
Enrollment
395 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic